Literature DB >> 15365805

Absorption phase cyclosporine (C(2h)) monitoring in the first weeks after pediatric renal transplantation.

Udo Vester1, Birgitta Kranz, Gisela Offner, Silvio Nadalin, Andreas Paul, Christoph E Broelsch, Peter E Hoyer.   

Abstract

Cyclosporine (CsA) monitoring using abbreviated area under the curve or 2-h blood concentration (C(2h))has been shown to predict total drug exposure in adult renal transplantation. However, pediatric experience is limited. Since 1998, we have monitored C(2h) in 45 children (age 10.6+4.7 years) during the first 6 weeks after transplantation. In 22 a 4-h CsA profile (AUC(0-4h)) was available and C(2h) in the remaining 23 patients. In addition CsA profiles from 24 children transplanted before 1998 were used to calculate the correlation between single time points and AUC(0-4h). The best correlation between AUC(0-4h) and a single time point was seen with C(2h) (r(2)=0.89). Coh did not predict AUC(0-4h) reliably (r(2)=0.27). C(2h) showed the lowest prediction error (10.0+9.6%).No dependency on age could be detected. In the first 3 months following transplantation, rejection was ob-served in 9 of 45 patients (20%). Glomerular filtration rate remained stable within the first 5 years after trans-plantation. In conclusion, in the early phase after renal transplantation, C(2h) can be used to predict drug exposure within the whole pediatric age group and should be evaluated in prospective trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365805     DOI: 10.1007/s00467-004-1617-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Therapeutic drug monitoring of cyclosporin A: should we use the area under the concentration-time curve and forget trough levels?

Authors:  P F Hoyer
Journal:  Pediatr Transplant       Date:  2000-02

Review 2.  Patient management by Neoral C(2) monitoring: an international consensus statement.

Authors:  Gary Levy; Eric Thervet; John Lake; Kazuharu Uchida
Journal:  Transplantation       Date:  2002-05-15       Impact factor: 4.939

3.  Abbreviated cyclosporine AUCs on Neoral--the search continues!

Authors:  G Filler; I Mai; S Filler; J H Ehrich
Journal:  Pediatr Nephrol       Date:  1999-02       Impact factor: 3.714

4.  Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study.

Authors:  Kamran Mahalati; Philip Belitsky; Kenneth West; Bryce Kiberd; Albert Fraser; Ingrid Sketris; Alan S Macdonald; Vivian McAlister; Joseph Lawen
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

5.  C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients.

Authors:  L T Weber; M Shipkova; V W Armstrong; O Mehls; M Oellerich; B Tönshoff
Journal:  Transplant Proc       Date:  2003-09       Impact factor: 1.066

6.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

7.  Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.

Authors: 
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

8.  The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.

Authors:  M Seikaly; P L Ho; L Emmett; A Tejani
Journal:  Pediatr Transplant       Date:  2001-06

9.  A strategy to calculate cyclosporin A area under the time-concentration curve in pediatric renal transplantation.

Authors:  Elias David-Neto; Lilian Pereira Araujo; Cristiane Feres Alves; Nairo Sumita; Pascoalina Romano; Elisa Midori Yagyu; William Carlos Nahas; Luiz Estevam Ianhez
Journal:  Pediatr Transplant       Date:  2002-08

10.  Comparison of cyclosporine absorption profiles over a 12-month period in stable pediatric renal transplant recipients.

Authors:  M Wigger; E Drückler; J Muscheites; H J Stolpe; G Kundt; R Wacke
Journal:  Transplant Proc       Date:  2003-06       Impact factor: 1.066

View more
  2 in total

Review 1.  Therapeutic drug monitoring in pediatric renal transplantation.

Authors:  Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2014-04-25       Impact factor: 3.714

Review 2.  Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

Authors:  Laure Elens; Loralie J Langman; Dennis A Hesselink; Stein Bergan; Dirk Jan A R Moes; Mariadelfina Molinaro; Raman Venkataramanan; Florian Lemaitre
Journal:  Ther Drug Monit       Date:  2020-06       Impact factor: 3.681

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.